Nedosiran sodium 是一种靶向乳酸脱氢酶 (LDH) 的 RNA 干扰剂 (RNAi)。Nedosiran sodium 可用于研究并发终末期肾病 (ESRD)的原发性高草酸尿症 (PH)。 详细介绍 MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 Nedosiran sodium ...
英文名称:Nedosiran Sodium CAS:2247026-22-6 其它信息:纯度:98% | 包装信息:1G:5G 欧利希(上海)医药科技有限公司 联系电话:17316404525 电子邮件:209533805@qq.com CB指数:58 网址:www.olix.cn 相关信息:产品目录(9970)用户评价 公司动态:欧利希医药拥有专业而经验丰富的团队提供智能化、自动化的药物化学,合成...
(2-Hydroxypropyl)-β-cyclodextrin | 5-Ph-IAA | Digitonin | Methyl-β-cyclodextrin | Tocofersolan | Biotin | CFSE | Yoda 1 | 3X FLAG peptide TFA | O-Propargyl-Puromycin | Cremophor EL | GsMTx4 TFA | DTT | Monocrotaline | FLAG peptide | Thiazolyl Blue | Nile Red | IPTG | Sodium ...
<30 mL/min/1.73 m2 (CKD Stages 4/5; on hemodialysis [Groups 1a, 1b] and not on hemodialysis [Group 2]) and 10 participants with normal kidney function (estimated glomerular filtration rate ≥90 mL/min/1.73 m2; Group 3) received a single dose of subcutaneous nedosiran sodium...
Based on the available modeling and simulation data, a fixed monthly dose of nedosiran 160 mg (free acid; equivalent to 170 mg sodium salt) in adults was associated with the highest proportion of simulated individuals achieving normal or near-normal 24-hour urinary oxalate excretion and fewest ...